At a glance
ClinicalIndex Comparison RecordN/ACompleted· 43 enrolled
Drug / intervention
esomeprazole +1 moredrug
Likely dose
esomeprazole 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial
University of Texas Southwestern Medical Center·interventional·Posted Sep 3, 2008·Updated Jun 11, 2019
In Brief
A clinical study evaluating esomeprazole and placebo for Vasomotor Rhinitis. Completed, enrolled 43 participants across 1 site.
Detailed Summary
The purpose of this study was to see if high dose esomeprazole (40mg bid) was effective in treating non-allergic rhinitis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVasomotor Rhinitis
CountriesUnited States
CollaboratorsAstraZeneca
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2005
Primary CompletionMar 2008
First PostedSep 2008
TodayJul 2026
First PostedSep 3, 2008
Enrollment StartJun 1, 2005
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.8 years ago
Interventions
esomeprazoledrug
40mg by mouth twice daily
placebodrug